-
1
-
-
23944479368
-
Potential impact of antiviral drug use during influenza pandemic
-
Gani R, Hughes H, Fleming D, Griffin T, Medlock J, Leach S. Potential impact of antiviral drug use during influenza pandemic. Emerg Infect Dis J. 2005;11:1355-62.
-
(2005)
Emerg Infect Dis J
, vol.11
, pp. 1355-1362
-
-
Gani, R.1
Hughes, H.2
Fleming, D.3
Griffin, T.4
Medlock, J.5
Leach, S.6
-
2
-
-
0037402154
-
The epidemiology and clinical impact of pandemic influenza
-
Nguyen-Van-Tam JS, Hampson AW. The epidemiology and clinical impact of pandemic influenza. Vaccine. 2003;1762-8.
-
(2003)
Vaccine
, pp. 1762-1768
-
-
Nguyen-Van-Tam, J.S.1
Hampson, A.W.2
-
5
-
-
25444432780
-
-
The Writing Committee of the World Health Organization (WHO) consultation on human influenza A/H5. N Engl J Med. 2005;353:1374-85.
-
(2005)
N Engl J Med
, vol.353
, pp. 1374-1385
-
-
-
7
-
-
29944444522
-
Plan nacional de preparación y respuesta ante una pandemia de gripe
-
Mayo de
-
Plan nacional de preparación y respuesta ante una pandemia de gripe. Ministerio de Sanidad y Consumo. Mayo de 2005.
-
(2005)
Ministerio de Sanidad Y Consumo
-
-
-
8
-
-
0344395604
-
Are we ready for pandemic influenza?
-
Webby RJ, Webster RG. Are we ready for pandemic influenza? Science. 2003;302:1519-22.
-
(2003)
Science
, vol.302
, pp. 1519-1522
-
-
Webby, R.J.1
Webster, R.G.2
-
9
-
-
0038037687
-
Pandemic influenza and the global vaccine supply
-
Fedson DS. Pandemic influenza and the global vaccine supply. Clin Infect Dis. 2003;46:1552-61.
-
(2003)
Clin Infect Dis
, vol.46
, pp. 1552-1561
-
-
Fedson, D.S.1
-
10
-
-
11144356405
-
Responsiveness to a pandemic alert: Use of reverse genetics for rapid development of influenza vaccines
-
Webby RJ, Pérez DR, Coleman JS. Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines. Lancet. 2004;363:1099-103.
-
(2004)
Lancet
, vol.363
, pp. 1099-1103
-
-
Webby, R.J.1
Pérez, D.R.2
Coleman, J.S.3
-
11
-
-
0032934765
-
Profilaxis y tratamiento de las infecciones respiratorias causadas por los virus Influenza a y B
-
Reina J. Profilaxis y tratamiento de las infecciones respiratorias causadas por los virus Influenza A y B. Rev Esp Quimioterap. 1999;12:23-9.
-
(1999)
Rev Esp Quimioterap
, vol.12
, pp. 23-29
-
-
Reina, J.1
-
12
-
-
3142579867
-
Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia
-
Li KS, Guan Y, Wang J, Smith GJD, Xu KM, Duan L, et al. Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. Nature. 2004;430:209-13.
-
(2004)
Nature
, vol.430
, pp. 209-213
-
-
Li, K.S.1
Guan, Y.2
Wang, J.3
Smith, G.J.D.4
Xu, K.M.5
Duan, L.6
-
13
-
-
0017151109
-
Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N- Trifluoroacetyl -neuraminic acid (FANA): Mechanisms of action
-
Palese P, Compans RW. Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N- trifluoroacetyl -neuraminic acid (FANA): mechanisms of action. J Gen Virol. 1976;33:159-63.
-
(1976)
J Gen Virol
, vol.33
, pp. 159-163
-
-
Palese, P.1
Compans, R.W.2
-
14
-
-
0020633096
-
Structure of the catalytic and antigenic sites in influenza virus neuraminidase
-
Colman PM, Verghese JN, Laver WG. Structure of the catalytic and antigenic sites in influenza virus neuraminidase. Nature. 1983;303:41-4.
-
(1983)
Nature
, vol.303
, pp. 41-44
-
-
Colman, P.M.1
Verghese, J.N.2
Laver, W.G.3
-
15
-
-
0027287506
-
Rational design of potent sialidase-based inhibitors of influenza virus replication
-
Von Itzstein M, Wu WY. Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature. 1993;363:418-23.
-
(1993)
Nature
, vol.363
, pp. 418-423
-
-
Von Itzstein, M.1
Wu, W.Y.2
-
16
-
-
0027981472
-
Inhibition of influenza virus replication in mice by GG167 is consistent with extracellular activity of viral neuraminidase (sialidase)
-
Ryan DM, Ticehurst J, Dempsey MH, Coates JA, Bethell RC. Inhibition of influenza virus replication in mice by GG167 is consistent with extracellular activity of viral neuraminidase (sialidase). Antimicrob Agents Chemother. 1994;38:2270-5.
-
(1994)
Antimicrob Agents Chemother
, vol.38
, pp. 2270-2275
-
-
Ryan, D.M.1
Ticehurst, J.2
Dempsey, M.H.3
Coates, J.A.4
Bethell, R.C.5
-
17
-
-
0028049979
-
Anti-influenza virus activity of the neuraminidase inhibitor 4-guanidino-Neu5Ac2en in cell culture and in human respiratory epithelium
-
Hayden FG, Rollins BS, Madren LK. Anti-influenza virus activity of the neuraminidase inhibitor 4-guanidino-Neu5Ac2en in cell culture and in human respiratory epithelium. Antiviral Res. 1994;25:123-31.
-
(1994)
Antiviral Res
, vol.25
, pp. 123-131
-
-
Hayden, F.G.1
Rollins, B.S.2
Madren, L.K.3
-
18
-
-
0034603350
-
Influenza virus neuraminidase inhibitors
-
Gubareva LV, Kaiser L, Hayden FG. Influenza virus neuraminidase inhibitors. Lancet. 2000;355:827-35.
-
(2000)
Lancet
, vol.355
, pp. 827-835
-
-
Gubareva, L.V.1
Kaiser, L.2
Hayden, F.G.3
-
19
-
-
0037279614
-
Treatmernt of epidemic and pandemic influenza with neuraminidase and M2 proton channel inhibitors
-
Oxford JS, Bossuyt S, Balasingam S, Mann A, Novelli P, Lambkin R. Treatmernt of epidemic and pandemic influenza with neuraminidase and M2 proton channel inhibitors. Clin Microbiol Infect. 2003;9:1-14.
-
(2003)
Clin Microbiol Infect
, vol.9
, pp. 1-14
-
-
Oxford, J.S.1
Bossuyt, S.2
Balasingam, S.3
Mann, A.4
Novelli, P.5
Lambkin, R.6
-
20
-
-
47549118248
-
Oseltamvir
-
Oxford J. Oseltamvir. Drugs in Context. 2004;1:313-56.
-
(2004)
Drugs in Context
, vol.1
, pp. 313-356
-
-
Oxford, J.1
-
21
-
-
0034720503
-
Efficacy and safety of oseltamivir in treatment of acute influenza: A randomised controlled trial. Neuraminidase inhibitor flu treatment investigator group
-
Nicholson KG, Aoki FY, Osterhaus AD, Trottier S, Carewicz O, Mercier CH, et al. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase inhibitor flu treatment investigator group. Lancet. 2000;355:1845-50.
-
(2000)
Lancet
, vol.355
, pp. 1845-1850
-
-
Nicholson, K.G.1
Aoki, F.Y.2
Osterhaus, A.D.3
Trottier, S.4
Carewicz, O.5
Mercier, C.H.6
-
22
-
-
20444436368
-
Human infection by avian influenza a H5N1
-
Yuen KY, Wong SSY. Human infection by avian influenza A H5N1. Hong Kong Med J. 2005;11:189-99.
-
(2005)
Hong Kong Med J
, vol.11
, pp. 189-199
-
-
Yuen, K.Y.1
Wong, S.S.Y.2
-
23
-
-
0033651178
-
The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses
-
Leneva IA, Roberts N, Govorkova EA, Goloubeva OG, Webster RG. The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses. Antiviral Res. 2000;48:101-15.
-
(2000)
Antiviral Res
, vol.48
, pp. 101-115
-
-
Leneva, I.A.1
Roberts, N.2
Govorkova, E.A.3
Goloubeva, O.G.4
Webster, R.G.5
-
24
-
-
0034801450
-
Comparison of efficacies of RWJ-270201, zanamivir and oseltamivir against H5N1, H9N2 and other avian influenza viruses
-
Govorkova E, Leneva IA, Goloubeva OG, Bush K, Webster RG. Comparison of efficacies of RWJ-270201, zanamivir and oseltamivir against H5N1, H9N2 and other avian influenza viruses. Antimicrob Agent Chemother. 2001;45:2723-32.
-
(2001)
Antimicrob Agent Chemother
, vol.45
, pp. 2723-2732
-
-
Govorkova, E.1
Leneva, I.A.2
Goloubeva, O.G.3
Bush, K.4
Webster, R.G.5
-
26
-
-
23244456655
-
Virulence may determine the necessary duration and dosage of oseltamivir treatment for highly pathogenic A/Vietnam/1203/04 influenza virus in mice
-
Yen HL, Monto AS, Webster RG, Govorkova EA. Virulence may determine the necessary duration and dosage of oseltamivir treatment for highly pathogenic A/Vietnam/1203/04 influenza virus in mice. J Infect Dis. 2005;192:665-72.
-
(2005)
J Infect Dis
, vol.192
, pp. 665-672
-
-
Yen, H.L.1
Monto, A.S.2
Webster, R.G.3
Govorkova, E.A.4
-
27
-
-
4444369826
-
Resistant influenza a viruses in children treated with oseltamivir: Descriptive study
-
Kiso M, Mitamura K, Sakai-Tagawa Y, Shiraishi K, Kawakami C, Kimura K, et al. Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet. 2004;364:759-65.
-
(2004)
Lancet
, vol.364
, pp. 759-765
-
-
Kiso, M.1
Mitamura, K.2
Sakai-Tagawa, Y.3
Shiraishi, K.4
Kawakami, C.5
Kimura, K.6
-
29
-
-
0031978256
-
Emergence of drug resistance during an influenza epidemic: Insights from a mathematical model
-
Stilianakis NL, Perelson AS, Hayden FG. Emergence of drug resistance during an influenza epidemic: insights from a mathematical model. J Infect Dis. 1998;177:863-73.
-
(1998)
J Infect Dis
, vol.177
, pp. 863-873
-
-
Stilianakis, N.L.1
Perelson, A.S.2
Hayden, F.G.3
-
30
-
-
0037397232
-
A population-dynamic model for evaluating the potential spread of drug-resistant influenza virus infections during community-based use of antivirals
-
Ferguson NM, Mallett S, Jackson H, Roberts N, Ward P. A population-dynamic model for evaluating the potential spread of drug-resistant influenza virus infections during community-based use of antivirals. J Antimicrob Chemother. 2003;51:977-90.
-
(2003)
J Antimicrob Chemother
, vol.51
, pp. 977-990
-
-
Ferguson, N.M.1
Mallett, S.2
Jackson, H.3
Roberts, N.4
Ward, P.5
-
32
-
-
23944479368
-
Potential impact of antiviral drug use during influenza pandemic
-
Gani R, Hughes H, Fleming D, Griffin T, Medlock J, Leach S. Potential impact of antiviral drug use during influenza pandemic. Emerg Infect Dis J. 2005;11:1355-62.
-
(2005)
Emerg Infect Dis J
, vol.11
, pp. 1355-1362
-
-
Gani, R.1
Hughes, H.2
Fleming, D.3
Griffin, T.4
Medlock, J.5
Leach, S.6
-
33
-
-
0032741256
-
The economic impact of pandemic influenza in the United States: Priorities for intervention
-
Meltzer MI, Cox NJ, Fukuda K. The economic impact of pandemic influenza in the United States: priorities for intervention. Emerg Infect Dis J. 1999;5:659-71.
-
(1999)
Emerg Infect Dis J
, vol.5
, pp. 659-671
-
-
Meltzer, M.I.1
Cox, N.J.2
Fukuda, K.3
-
35
-
-
0037636478
-
Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir
-
McKimm-Breschkin J, Trivedi T, Hampson A, Hay A, Klimov M, Tashiro M, et al. Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir. Antimicrob Agents Chemother. 2003;47:2264-72.
-
(2003)
Antimicrob Agents Chemother
, vol.47
, pp. 2264-2272
-
-
McKimm-Breschkin, J.1
Trivedi, T.2
Hampson, A.3
Hay, A.4
Klimov, M.5
Tashiro, M.6
-
36
-
-
0036224388
-
Influenza virus carrying neuraminidase with reduced sensitivity to oseltamivir carboxylate has altered properties in vitro and is compromised for infectivity and replicative ability in vivo
-
Carr J, Ives J, Kelly L, Lambkin R, Oxford J, Mendel D, et al. Influenza virus carrying neuraminidase with reduced sensitivity to oseltamivir carboxylate has altered properties in vitro and is compromised for infectivity and replicative ability in vivo. Antiviral Res. 2002;54:79-88.
-
(2002)
Antiviral Res
, vol.54
, pp. 79-88
-
-
Carr, J.1
Ives, J.2
Kelly, L.3
Lambkin, R.4
Oxford, J.5
Mendel, D.6
-
37
-
-
0036294323
-
The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo
-
Ives J, Carr J, Mendel D, Tai CY, Lambkin R, Kelly L, et al. The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo. Antiviral Res. 2002;55:307-17.
-
(2002)
Antiviral Res
, vol.55
, pp. 307-317
-
-
Ives, J.1
Carr, J.2
Mendel, D.3
Tai, C.Y.4
Lambkin, R.5
Kelly, L.6
-
38
-
-
0034603350
-
Influenza virus neuraminidase inhibitors
-
Gubareva LV, Kaiser L, Hayden FG. Influenza virus neuraminidase inhibitors. Lancet. 2000;355:827-35.
-
(2000)
Lancet
, vol.355
, pp. 827-835
-
-
Gubareva, L.V.1
Kaiser, L.2
Hayden, F.G.3
-
39
-
-
0033897803
-
Resistance of influenza viruses to neuraminidase inhibitors: A review
-
McKimm-Breschkin J. Resistance of influenza viruses to neuraminidase inhibitors: a review. Antiviral Res. 2000;47:1-17.
-
(2000)
Antiviral Res
, vol.47
, pp. 1-17
-
-
McKimm-Breschkin, J.1
-
40
-
-
0035190544
-
Comparison of the activities of zanamivir, oseltamivir and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants
-
Gubareva LV, Webster RG, Hayden FG. Comparison of the activities of zanamivir, oseltamivir and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants. Antimicrob Agents Chemother. 2001;45:3403-8.
-
(2001)
Antimicrob Agents Chemother
, vol.45
, pp. 3403-3408
-
-
Gubareva, L.V.1
Webster, R.G.2
Hayden, F.G.3
-
41
-
-
27144468290
-
Isolation of drug-resistant H5N1 virus
-
14 de octubre, on line
-
Le QM, Kiso M, Someya K, Sakai YT, Nguyen TH, Nguyen KH, et al. Isolation of drug-resistant H5N1 virus. Nature. 2005 (14 de octubre, on line).
-
(2005)
Nature
-
-
Le, Q.M.1
Kiso, M.2
Someya, K.3
Sakai, Y.T.4
Nguyen, T.H.5
Nguyen, K.H.6
-
42
-
-
0036090557
-
Functional balance between haemagglutinin and neuraminidase in influenza virus infections
-
Wagner R, Matrosovich M, Klenk HD. Functional balance between haemagglutinin and neuraminidase in influenza virus infections. Rev Med Virol. 2002;12:159-66.
-
(2002)
Rev Med Virol
, vol.12
, pp. 159-166
-
-
Wagner, R.1
Matrosovich, M.2
Klenk, H.D.3
-
43
-
-
25844474747
-
Neuraminidase inhibitor-resistant influenza viruses may differ substantially in fitness and transmissibility
-
Yen HL, Herlocher LM, Hoffmann E, Matrosovich MN, Monto AS, Webster RG, et al. Neuraminidase inhibitor-resistant influenza viruses may differ substantially in fitness and transmissibility. Antimicrob Agents Chemother. 2005;49:4075-84.
-
(2005)
Antimicrob Agents Chemother
, vol.49
, pp. 4075-4084
-
-
Yen, H.L.1
Herlocher, L.M.2
Hoffmann, E.3
Matrosovich, M.N.4
Monto, A.S.5
Webster, R.G.6
-
44
-
-
0036228067
-
Influenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferrets
-
Herlocher ML, Carr J, Ives J, Elias S, Truscon R, Roberts N, et al. Influenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferrets. Antiviral Res. 2002;54:99-111.
-
(2002)
Antiviral Res
, vol.54
, pp. 99-111
-
-
Herlocher, M.L.1
Carr, J.2
Ives, J.3
Elias, S.4
Truscon, R.5
Roberts, N.6
|